— Know what they know.
Not Investment Advice

PHIL.MI MIL

Philogen S.p.A.
1W: -1.8% 1M: -4.1% 3M: -9.8% YTD: +3.7% 1Y: -5.9% 3Y: +34.5%
€22.20 ($24.83)
-0.10 (-0.45%)
 
Weekly Expected Move ±3.5%
€21 €21 €22 €23 €24
MIL · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · €641.1M mcap · 11M float · 0.192% daily turnover

Balance Sheet Trends

Total Assets
$168M +41.2% ▲
5Y CAGR: +11.8%
Total Liabilities
$30M +3.9% ▲
5Y CAGR: +1.6%
Shareholders Equity
$139M +53.1% ▲
5Y CAGR: +15.0%
Cash & Investments
$114M +50.9% ▲
5Y CAGR: +8.8%
Total Debt
$12M -22.8% ▼
5Y CAGR: -3.6%
Net Debt
-$19M -2548.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$12M$9M$24M$16M$31M
Short-Term Investments$50M$93M$62M$60M$83M
Cash & ST Investments$62M$102M$86M$75M$114M
Net Receivables$5M$1M$4M$3M$15M
Inventory$774K$1M$2M$2M$3M
Other Current Assets$106K-$260K-$408K$279K-$304K
Total Current Assets$68M$110M$99M$89M$132M
Property, Plant & Equip.$15M$21M$23M$26M$26M
Goodwill & Intangibles$962K$950K$1M$1M$1M
Long-Term Investments$0$0$0$0$1K
Other Non-Current Assets-$1K$0$3M$3M$185K
Total Non-Current Assets$18M$23M$27M$30M$36M
Total Assets$85M$133M$126M$119M$168M
— Liabilities —
Accounts Payable$4M$6M$6M$8M$10M
Short-Term Debt$1M$1M$884K$889K$0
Deferred Revenue$8M$2M$0$0$0
Other Current Liabilities-$1M$740K$1M$2M$4M
Total Current Liabilities$13M$12M$11M$13M$17M
Long-Term Debt$5M$4M$3M$2M$0
Other Non-Current Liab.$847K$1K$960K$1M$1M
Total Non-Current Liabilities$17M$16M$17M$16M$13M
Total Liabilities$30M$28M$28M$29M$30M
— Equity —
Common Stock$5M$6M$6M$6M$6M
Retained Earnings-$13M-$20M-$12M-$12M$40M
Accumulated OCI-$122K$468K$602K$2M$4M
Total Stockholders Equity$56M$105M$98M$91M$139M
Total Liabilities & Equity$85M$133M$126M$119M$168M
— Key Metrics —
Total Debt$18M$16M$16M$15M$12M
Net Debt$23K$3M-$13M-$720K-$19M
Total Investments$50M$93M$62M$60M$83M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms